AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 81 filers reported holding AVROBIO INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $647,918 | +40.3% | 647,918 | 0.0% | 0.17% | +40.0% |
| Q4 2022 | $461,901 | +11.0% | 647,918 | 0.0% | 0.12% | +21.2% |
| Q3 2022 | $416,000 | -30.2% | 647,918 | 0.0% | 0.10% | -40.4% |
| Q2 2022 | $596,000 | -30.3% | 647,918 | 0.0% | 0.17% | -27.5% |
| Q1 2022 | $855,000 | -65.7% | 647,918 | 0.0% | 0.23% | -49.7% |
| Q4 2021 | $2,494,000 | -48.1% | 647,918 | -24.8% | 0.46% | -39.0% |
| Q3 2021 | $4,809,000 | -5.3% | 861,858 | +136.6% | 0.75% | +69.9% |
| Q4 2020 | $5,078,000 | – | 364,285 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
| Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
| MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
| GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
| New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
| Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
| Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
| XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
| Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |